Gastroenterology Clinical Trials

Studies indicate that over half a million individuals in the United States are affected by Crohn’s disease, with research suggesting an increasing prevalence of the condition over time within the country. Crohn’s disease, a chronic inflammatory condition affecting the digestive tract, poses persistent challenges for sufferers due to its debilitating symptoms.

Crohn’s disease manifests in various symptoms, ranging from abdominal pain and diarrhea to fatigue and weight loss. It profoundly impacts the daily lives of those afflicted with it.

Hightower Clinical Research is developing innovative drug therapies to combat inflammation and enhance the well-being of patients with moderate to severe disease manifestations.

Ulcerative colitis is a form of inflammatory bowel disease and presents a significant health challenge affecting millions worldwide. In the United States alone, approximately 907,000 individuals grapple with this chronic condition, with its incidence steadily rising over recent years. It is usually caused by environmental or physiological factors.

Furthermore, as ulcerative colitis is associated with an increased risk of colorectal cancer, their research may also have implications for cancer prevention.

Hightower Clinical is actively tackling this pressing medical issue by leading investigations into the efficacy and safety of innovative drugs tailored specifically for ulcerative colitis treatment.